DiaDeep is a biotechnology startup with a compelling mission encapsulated by its slogan, "Every patient matters, every decision counts!" The company, founded in 2022 and headquartered in France, addresses the critical decision-making challenges faced by pathologists and oncologists worldwide in the context of cancer treatment. DiaDeep's Ai Copilot applications leverage AI technology and histology slides to assist in decision-making, biomarker quantification, and prognosis prediction for various cancers like breast cancer and melanoma. The potential of DiaDeep's unique approach is evident in its critical role to provide real-time insights, ultimately empowering pathologists and oncologists and reinforcing their decision-making processes.
There is no investment information
No recent news or press coverage available for DiaDeep.